Statin Use is Associated with Better Cognitive Function in Elderly with Type 2 Diabetes

Area of Science:

• Neurology
• Endocrinology
• Pharmacology

Background:

• The impact of statins on cognitive function remains unclear, particularly in individuals with type 2 diabetes.
• Statins are widely prescribed cholesterol-lowering drugs with potential pleiotropic effects beyond lipid modification.

Purpose of the Study:

• To investigate the association between statin use and cognitive performance in patients with type 2 diabetes.
• To determine if any observed cognitive benefits are independent of cholesterol levels.

Main Methods:

• A cohort study comparing 45 statin users (used statins >=90% of the time) with 61 non-statin users from the Israel Diabetes and Cognitive Decline Study.
• Analysis of covariance (ANCOVA) was used to compare mean cognitive z-scores, adjusting for demographic, diabetes-related, and cardiovascular factors, including cholesterol changes.

Main Results:

• Statin users demonstrated significantly better overall cognition compared to non-users (p < 0.0008).
• Improvements were observed in memory and executive function domains for statin users.
• The positive association between statin use and cognitive function persisted even after accounting for cholesterol level changes.

Conclusions:

• Statin therapy appears to have a beneficial effect on cognitive function in type 2 diabetes patients.
• This cognitive enhancement may be independent of the cholesterol-lowering effects of statins.
• Further research is warranted to elucidate the mechanisms behind statins' neuroprotective effects in this population.